A molecular pathway behind diet-associated cognitive changes
High-calorie diets are widely associated with obesity, diabetes and other metabolic disorders. A new mouse study from researchers at the Institute of Science Tokyo examines a more specific question: how might a high-fat diet affect the brain at a molecular level?
The work points to a nuclear protein called PQBP1 as a possible link. In mice fed a high-fat diet, the researchers found reduced expression of PQBP1. That reduction was associated with altered alternative RNA splicing in genes involved in synaptic function, along with synaptic abnormalities and cognitive impairment.
The findings do not establish that the same pathway operates in people, and the experiments were conducted in mice. But they offer a more detailed biological explanation for an association that has drawn increasing attention: calorie-rich diets may affect more than metabolism.
Why RNA splicing matters
Genes are not simply switched on to produce one fixed protein. Cells often process the RNA copied from genes in different ways, a process known as alternative splicing. This lets a cell make different protein forms from the same genetic instructions and can be particularly important in specialized tissues such as the brain.
The study identifies PQBP1-dependent RNA splicing as a candidate mechanism in diet-associated cognitive impairment. When high-fat feeding reduced PQBP1 expression, splicing changes appeared in genes connected to synaptic function. Synapses are the junctions through which nerve cells communicate, so disruption to their structure or operation could plausibly affect learning and memory-related performance.
Previous work has already connected high-calorie diets with poorer cognitive performance and with higher risk of neurodegenerative conditions. Inflammation and insulin resistance have also been considered important contributors. The new research does not rule out those processes; instead, it focuses attention on a neuronal mechanism that may sit closer to changes in brain circuitry.
Testing ways to restore PQBP1
The researchers also tested interventions intended to restore PQBP1 levels in the mice. Treatment with pioglitazone, as well as delivery of AAV-PQBP1, improved synaptic and cognitive outcomes reported in the study.
That result makes the work more than a descriptive observation. It suggests that the PQBP1 pathway could be investigated as a therapeutic target. Still, a potential target is not a treatment. The source material describes preclinical mouse findings, and further work would be needed to establish how the pathway behaves in humans, what changes are safe to make, and whether any intervention would provide a meaningful clinical benefit.
What the result does and does not say
The study adds detail to the scientific picture of how diet may influence the brain, but it should not be read as a direct dietary prescription for individuals. It does not show that a particular meal causes cognitive decline, nor does it demonstrate that a PQBP1-based intervention can prevent disease in people.
Its value is in narrowing a broad question into testable biological steps: a high-fat diet was associated with lower PQBP1 expression; lower PQBP1 was associated with changes in RNA splicing for synaptic genes; and those changes coincided with synaptic and cognitive effects in mice. The intervention experiments provide an early indication that the sequence may be modifiable.
Published in Molecular Psychiatry, the research gives future studies a defined pathway to examine. As evidence accumulates around the links among diet, metabolism and brain health, molecular studies such as this may help distinguish between broad correlations and the cellular processes that help produce them.
The next questions
- Whether the PQBP1-related changes found in mice also appear in human brain tissue or in relevant human studies.
- How the pathway interacts with inflammation, insulin resistance and other metabolic effects of calorie-rich diets.
- Which synaptic genes and brain circuits are most affected by the observed splicing changes.
- Whether approaches that restore PQBP1 can be translated safely beyond preclinical models.
For now, the study is a mechanistic advance rather than a clinical conclusion. It provides researchers with a concrete hypothesis for how a high-fat diet could be connected to synaptic disruption and impaired cognition—and with an early lead on where an intervention might be tested.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
